A clinical study to investigate gum infection in patients on kidney dialysis
| ISRCTN | ISRCTN17887630 |
|---|---|
| DOI | https://doi.org/10.1186/ISRCTN17887630 |
| ClinicalTrials.gov (NCT) | Nil known |
| Clinical Trials Information System (CTIS) | Nil known |
| Protocol serial number | EP-7326/14-11 |
| Sponsor | School of Dentistry University of Zagreb |
| Funder | investigator initiated and funded |
- Submission date
- 12/06/2019
- Registration date
- 17/06/2019
- Last edited
- 21/08/2020
- Recruitment status
- No longer recruiting
- Overall study status
- Completed
- Condition category
- Oral Health
Plain English summary of protocol
Background and study aims
There are many studies in the last few decades that established a connection of plaque-induced periodontitis with other systemic diseases. The connection between periodontitis and chronic kidney disease is also studied. Chronic kidney disease is a progressive illness characterized by nephron destruction. Primary causes for that destruction are diabetes, pyelonephritis, glomerulonephritis, nephrosclerosis, polycystic kidney disease and collagen vascular diseases. The loss of kidney function leads to an accumulation of harmful metabolic products that can affect various organs. Clinical progress that leads to kidney failure can be divided into three progressive stages: first decreased kidney reserve, then decreased kidney function and at the end kidney failure or uremia. The last stage is treated either by dialysis or kidney transplantation. There are two types of dialysis: hemodialysis and peritoneal dialysis. Hemodialysis is a procedure in which nitrogen and other toxic metabolic waste products are removed from the blood by the hemodialysis system. The change between the patient's blood plasma and dialysate is made through a semipermeable membrane that allow uremic toxins to flow from the blood plasma. In peritoneal dialysis, dialysis fluid (called dialysate) is infused into the peritoneal cavity through the patient's catheter. The fluid (approximately 1-2- litres) is held (dwells) within the abdomen for a prescribed period of time. Hemodialysis is usually conducted three times a week for 3-4 hours and peritoneal dialysis is conducted at home or another clean environment each day. Peritoneal dialysis is cheaper and according to some research, it has a higher survival rate in the first two to four years. There is evidence that the quality of life is also better with peritoneal dialysis. But the percentage of patients on hemodiyalysis is higher.
Aim of the study: to compare periodontal status between patients on hemodialysis and peritoneal dialysis, analyze main laboratory parameters in relation to periodontal indices and by means of questionnaire determine oral hygienic habits, smoking habits and alcohol consumption in relation to dialysis type and periodontal status and to establish the need for periodontal therapy.
Who can participate?
Patients aged 18 and over on dialysis (peritoneal or hemodialysis).
What does the study involve?
Patients that attend Clinic of Internal Medicine, University Hospital Center “Sestre milosrdnice”, Zagreb, Croatia and are on dialysis therapy (peritoneal or hemodialysis) are examined. All involved patients sign informed consent. The examination consists of taking periodontal indices: approximal plaque index, periodontal probing depth, periodontal bleeding index, bleeding on probing, gingival recession, clinical attachment level and calculation of periodontally inflamed surface area. All indices are measured at six sites on each tooth using a periodontal probe (PCP 15; Hu-Friedy, Chicago, IL, USA).
What are the possible benefits and risks of participating?
Benefits for the patients are free periodontal examination and free periodontal treatment if needed. The potential benefit is also decreased systemic inflammatory response and decreased mortality. There are no known risks.
Where is the study run from? Clinic of Internal Medicine, University Hospital Center “Sestre milosrdnice”, Zagreb, Croatia.
When is the study starting and how long is it expected to run for? February 2015-January 2016
Who is funding the study?
Funded by the main researcher.
Who is the main contact?
Bojana Križan Smojver
bojana.krizan@gmail.com
Contact information
Scientific
Department of Endodontics with Restorative Dentistry, Oral Medicine and Periodontology
Dental Clinic Zagreb
Ulica Ivana Perkovca 3
Zagreb
10000
Croatia
| 0000-0003-0247-5248 | |
| Phone | +38514803252 |
| bojana.krizan@gmail.com |
Scientific
Department of Periodontology
School of Dentistry
University of Zagreb
Gundulićeva 5
Zagreb
10000
Croatia
| Phone | +38598593831 |
|---|---|
| aurer@sfzg.hr |
Scientific
Clinic of Internal Medicine
University Hospital Center “Sestre milosrdnice"
Zagreb
10000
Croatia
| Phone | +385981641992 |
|---|---|
| karmela.altabas@gmail.com |
Study information
| Primary study design | Observational |
|---|---|
| Study design | Observational cross-sectional single-centre study |
| Secondary study design | Cross sectional study |
| Study type | Participant information sheet |
| Scientific title | Periodontal indices in patients on hemodialysis and peritoneal dialysis: cross-sectional study |
| Study objectives | Patients on peritoneal dialysis have better periodontal status than patients on hemodialysis. |
| Ethics approval(s) | 1. Approved 11/06/2014, Ethics committee University hospital center “Sestre milosrdnice” (Vinogradska cesta 29, HR-10000, Zagreb, Croatia; +385 13787111), ref: EP-7326/14-11 2. Approved 12/02/2015, Ethics committee School of Dental medicine, University of Zagreb (Gunduliceva 5, HR-10000 Zagreb, Croatia), ref: 05-PA-26-6/2015. |
| Health condition(s) or problem(s) studied | Periodontal infection in patients with end-stage kidney disease |
| Intervention | Before the dialysis procedure patients are examined by the same calibrated examiner. Patients fill a questionnaire about oral hygiene habits, alcohol consumption, smoking habits, education and sign informed consent. Laboratory tests that are usually taken on the day of dialysis are made available to the researcher by the Hospital. |
| Intervention type | Procedure/Surgery |
| Primary outcome measure(s) |
Periodontal inflamed surface area (PISA). It is calculated based on bleeding on probing (BOP), clinical attachment level (CAL) and recession (REC) that are performed at six sites on each tooth. PISA is calculated by the on-line calculator available at: www.parsprototo.info. |
| Key secondary outcome measure(s) |
1. Plaque index (Approximal plaque index API; Lange 1986.): approximal spaces in all four quadrants are measured only vestibular or oral and mark as presence or absence of plaque (+ or -). It is calculated as a percentage by the formula: API= number of sites with plaque (+)/ number of tested sites x 100 |
| Completion date | 15/01/2016 |
Eligibility
| Participant type(s) | Patient |
|---|---|
| Age group | Adult |
| Lower age limit | 18 Years |
| Sex | All |
| Target sample size at registration | 70 |
| Total final enrolment | 89 |
| Key inclusion criteria | 1. Aged >18 years 2. Kidney failure 3. Treated with hemodialysis or peritoneal dialysis. |
| Key exclusion criteria | 1. I-IV level of renal failure 2. Renal transplant patients |
| Date of first enrolment | 03/02/2014 |
| Date of final enrolment | 15/12/2015 |
Locations
Countries of recruitment
- Croatia
Study participating centre
Zagreb
10000
Croatia
Results and Publications
| Individual participant data (IPD) Intention to share | Yes |
|---|---|
| IPD sharing plan summary | Other |
| IPD sharing plan | All data generated or analysed during this study will be included in the subsequent results publication. |
Study outputs
| Output type | Details | Date created | Date added | Peer reviewed? | Patient-facing? |
|---|---|---|---|---|---|
| Results article | results | 03/04/2020 | 21/08/2020 | Yes | No |
| Participant information sheet | Participant information sheet | 11/11/2025 | 11/11/2025 | No | Yes |
Editorial Notes
21/08/2020: The following changes have been made:
1. Publication reference added.
2. The final enrolment number has been added from the reference.
14/06/2019: Trial’s existence confirmed by Ethics committee School of Dental medicine, University of Zagreb.